Sex video emerges in new twist to China's GlaxoSmithKline bribery scandal | South China Morning Post
  • Fri
  • Mar 6, 2015
  • Updated: 1:53am

GlaxoSmithKline

The London-based multinational drugmaker, also known as GSK, supplies key products such as vaccines in China, as well as drugs for lung disease and cancer. In 2013, the company was targeted by Chinese authorities over alleged corruption, price-fixing and quality controls.

BusinessChina Business
CORRUPTION ALLEGATIONS

Sex video emerges in new twist to China's GlaxoSmithKline bribery scandal

Spokesman confirms tape sent to company of former China head charged with corruption and Chinese girlfriend

PUBLISHED : Monday, 30 June, 2014, 11:17am
UPDATED : Monday, 30 June, 2014, 3:58pm

GlaxoSmithKline on Sunday confirmed the existence of an intimate video recording of its former China head, Mark Reilly, which The Sunday Times reported kicked off a bribery investigation that has damaged the drug maker’s business in China.

The Sunday Times said the recording was shot without Reilly’s knowledge or consent at his Shanghai flat and showed the Briton, who is separated from his wife, with his Chinese girlfriend.

It was not clear who shot the video or with what motivation. The video was e-mailed to top GSK executives in March last year, the newspaper said.

A GSK spokesman confirmed the tape existed but did not comment on how it related to the alleged bribery scandal.

In July last year, Chinese police accused Britain’s biggest pharmaceutical firm of transferring as much as 3 billion yuan (HK$3.64 billion) through travel agencies to bribe doctors and officials.

Reuters was not independently able to verify the link between the tape and the bribery case.

Chinese police filed corruption charges against Reilly last month. The Briton, who has been barred from leaving China, could face decades in prison.

Reilly has not been reachable for comment while his lawyer has declined to talk to the media. Reilly’s whereabouts are unknown.

China’s investigation into GSK and its scrutiny of numerous other foreign and local drugs companies have frightened foreign pharmaceutical executives so much that some fear they could be jailed and have asked their lawyers if they should temporarily leave the country.

GSK, which described the bribery allegations as “shameful” when they came to light last year, said on Sunday that it was continuing to cooperate fully with Chinese authorities on the ongoing investigation.

“The issues relating to our China business are very difficult and complicated,” it added in a statement.

The bribery case has hit GSK’s sales in China, as buyers have shied away from doing business with the company and GSK itself has revamped its sales and marketing model.

Bribery allegations involving GSK have come to light since then in other countries and GSK is now investigating claims that bribes were also paid to doctors in Poland, Iraq, Jordan and Lebanon.

Last month, Britain’s Serious Fraud Office launched a formal criminal investigation into GSK.

Share

Related topics

For unlimited access to:

SCMP.com SCMP Tablet Edition SCMP Mobile Edition 10-year news archive
 
 

 

 
 
 
 
 

Login

SCMP.com Account

or